Skip to main content

Human Neuroblastoma: Paradigm for a Tumor with Oncogene Amplification and Loss of a Putative Tumor Suppressor Gene

  • Conference paper
Modern Trends in Human Leukemia IX

Part of the book series: Haematology and Blood Transfusion / Hämatologie und Bluttransfusion ((HAEMATOLOGY,volume 35))

  • 51 Accesses

Abstract

Human neuroblastoma cells often carry nonrandom chromosomal abnormalities signaling genetic alterations. Quite frequent are “double minutes” (DMs) and homogeneously staining regions (HSRs), both cytogenetic manifestations of amplified DNA, and chromosome 1 p deletions indicating loss of genetic information. With the identification of amplified N-myc and the demonstration of a consensus deletion spanning the chromosome 1 p36.1–2 region it now appears likely that both amplification of a cellular oncogene and loss of a tumor suppressor gene play important roles in neuroblastoma (Fig.1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Schwab M, Amler LC (1990) Amplification of cellular oncogenes: a predictor of clinical outcome in human cancer. Genes Chromosomes Cancer 1:181–193

    Article  PubMed  CAS  Google Scholar 

  2. Schwab M, Alitalo K, Klempnauer KH, Varmus HE, Bishop JM, Gilbert F, Brodeur G, Goldstein M, Trent J (1983) Amplified DNA with limited homology of myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumor. Nature 305:245–248

    Article  PubMed  CAS  Google Scholar 

  3. Berthold F (1990) Biology of neuroblastoma. In: Pochedly C (ed) Neuroblastoma: tumor biology and therapy. CRC Press, Boca Raton Ann Arbor Bosten, pp 1–27

    Google Scholar 

  4. Schwab M, Varmus HE, Bishop JM (1985) The human N-myc gene contributes to tumorigenic conversion of mammalian cells in culture. Nature 316:160–162

    Article  PubMed  CAS  Google Scholar 

  5. Small M, Hay N, Schwab M, Bishop JM (1987) Neoplastic transformation by the human gene N-myc. Mol Cell Biol 7:1638–1645

    PubMed  CAS  Google Scholar 

  6. Schweigerer L, Breit S, Wenzel A, Tsunamoto K, Ludwig R, Schwab M (1990) Augmented MYCN expression advances the malignant phenotype and induces autocrine growth factor activity in human neuroblastoma cells. Cancer Res 50:4411–4416

    PubMed  CAS  Google Scholar 

  7. Schwab M, Bishop JM (1988) Sustained expression of the human protooncogene MYCN rescues rat embryo cells from senescence. Proc Natl Acad Sci USA 85:9585–9589

    Article  PubMed  CAS  Google Scholar 

  8. Van Lohuizen M, Breuer M, Berns A (1989) N-myc is frequently activated by proviral insertion in MuLV-induced T cell lymphomas. EMBO J 8:133–136

    PubMed  Google Scholar 

  9. Dildrop R, Ma A, Zimmermann K, Hsu E, Tesfaye A, de Pinho R, Alt F (1989) IgH enhancer-mediated deregulation of N-myc gene expression in transgenic mice: generation of lymphoid neoplasias that lack c-myc expression. EMBO J 8:1121–1128

    PubMed  CAS  Google Scholar 

  10. Rosenbaum H, Webb E, Adams JM, Cory S, Harris AW (1989) N-myc transgene promotes B lymphoid proliferation, elicits lymphomas and reveals cross-regulation with c-myc. EMBO J 8:749–755

    PubMed  CAS  Google Scholar 

  11. Ibson JM, Rabbits PH (1988) Sequence of a germ-line N-myc gene and amplification as a mechanism of activation. Oncogene 2:399–402

    PubMed  CAS  Google Scholar 

  12. Kanda N, Schreck R, Alt F, Bruns G, Baltimore D, Latt S (1983) Isolation of amplified DNA sequences from IMR-32 human neuroblastoma cells: facilitation by fluorescence-activated flow-sorting of metaphase chromosomes. Proc Natl Acad Sci USA 80:4069–4073

    Article  PubMed  CAS  Google Scholar 

  13. Shiloh Y, Shipley J, Brodeur GM, Bruns G, Korf B, Donlon T, Schreck RR, Seeger T, Sakai K, Latt SA (1985) Differential amplification, assembly, and relocation of multiple DNA sequences in human neuroblastomas and neuroblastoma cell lines. Proc Natl Acad Sci USA 82:3761–3765

    Article  PubMed  CAS  Google Scholar 

  14. Shiloh Y, Korf B, Kohl NE, Sakai K, Brodeur GM, Harris P, Kanda N, Seeger RC, Alt FW, Latt SA (1986) Amplification and rearrangement of DNA sequences from the chromosomal region 2p24 in human neuroblastomas. Cancer Res 46:5297–5301

    PubMed  CAS  Google Scholar 

  15. Zehnbauer BA, Small D, Brodeur GM, Seeger R, Vogelstein B (1988) Characterization of NMYC amplification units in human neuroblastoma cells. Mol Cell Biol 8:522–530

    PubMed  CAS  Google Scholar 

  16. Tonin PN, Yeger H, Stallings RL, Srinavasan PR, Lewis WH (1989) Amplification of N-myc and ornithine decarboxylase genes in human neuroblastoma and hydroxyuera-resistant hamster cell lines. Oncogene 4:1117–1121

    PubMed  CAS  Google Scholar 

  17. Roninson I (1983) Detection and mapping of homologous, repeated and amplified DNA sequences by DNA renaturation in agarose gels. Nucleic Acids Res 11:5413–5431

    Article  PubMed  CAS  Google Scholar 

  18. Kinzler KW, Zehnbauer BA, Brodeur GM, Seeger RC, Trent J, Meltzer PS, Vogelstein B (1986) Amplification units containing human MYCN and MYC genes. Proc Natl Acad Sci USA 83:1031–1035

    Article  PubMed  CAS  Google Scholar 

  19. Amler LC, Schwab M (1989) Amplified N-myc in human neuroblastoma cells is often arranged as clustered tandem repeats of differently recombined DNA. Mol Cell Biol 9:4903–4913

    PubMed  CAS  Google Scholar 

  20. Schwab M, Varmus HE, Bishop JM, Grzeschik KH, Sakaguchi A, Brodeur G, Trent J (1984) Chromosome localization in normal human cells and neuroblastomas of a gene related to c-myc. Nature 308:288–291

    Article  PubMed  CAS  Google Scholar 

  21. Stark GR, Debatisse M, Giulotto E, Wahl GM (1989) Recent progress in understanding mechanisms of mammalian DNA amplification. Cell 57:901–908

    Article  PubMed  CAS  Google Scholar 

  22. Bartram CR, Berthold F (1987) Amplification and expression of the N-myc gene in neuroblastoma. Eur J Pediatr 146:162–165

    Article  PubMed  CAS  Google Scholar 

  23. Brodeur G, Seeger RC, Schwab M, Varmus HE, Bishop JM (1984) Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224:1121–1124

    Article  PubMed  CAS  Google Scholar 

  24. Nakagawara A, Ikeda K, Tsuda T, Hig-ashi K (1988) Biological characteristics of NMYC amplified neuroblastoma in patients over one year of age. In: Evans A, d’Angio G, Knudson A, Seeger RC (eds) Advances in neuroblastoma research. Liss, New York, pp 31–39

    Google Scholar 

  25. Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel WE, Wong KY, Hammond D (1985) Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313:1111–1116

    Article  PubMed  CAS  Google Scholar 

  26. Carlsen NLT, Christensen IJ, Schroeder H, Bro PV, Hesselberg K, Jensen KB, Nielsen OH (1986) Prognostic value of different staging systems in neuroblastomas and completeness of tumour excision. Archives Disease Childhood 61:832–842

    Article  CAS  Google Scholar 

  27. Cohn SL, Herst CV, Maurer HS, Rosen ST (1987) N-myc amplification in an infant with stage IV-s neuroblastoma. J Clin Oncol 5:1441–1444

    PubMed  CAS  Google Scholar 

  28. Tonini GP, Verdona G, de Bernardi B, Sansone R, Massimo L, Cornaglia-Ferraris P (1987) N-myc oncogene amplification in a patient with IV-s neuroblastoma. Am J Pediat Hematol Oncol 9:8–10

    Article  CAS  Google Scholar 

  29. Biedler JL, Helson L, Spengler BS (1973) Morphology and growth, tumorigenecity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 33:2643–2652

    PubMed  CAS  Google Scholar 

  30. Brodeur GM, Green AA, Hayes FA, Williams KJ, Williams DL, Tsiatis AA (1981) Cytogenetic features of human neuroblastomas and cell lines. Cancer Res 41:4678–4686

    PubMed  CAS  Google Scholar 

  31. Hansen MF, Cavanee WK (1987) Genetics of cancer predisposition. Cancer Res 47:5518–5527

    PubMed  CAS  Google Scholar 

  32. Martinsson T, Weith A, Cziepluch C, Schwab M (1986) Chromosome 1 deletions in human neuroblastomas: generation and fine mapping of microclones from the distal 1 p region. Genes Chromosomes Cancer 1:67–78

    Article  Google Scholar 

  33. Weith A, Martinsson T, Cziepluch C, Brüderlein S, Amler LC, Berthold F, Schwab M (1989) Neuroblastoma consensus deletion maps to chromosome lp36.1–2. Genes Chromosomes Cancer 1:159–166

    Article  PubMed  CAS  Google Scholar 

  34. Fong CT, Dracopoli NC, White P, Merrill PT, Griffith RC, Housman DE, Brodeur GM (1989) Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: Correlation with N-myc amplification. Proc Natl Acad Sci USA 86:3753–3757

    Article  PubMed  CAS  Google Scholar 

  35. Vogel F, Motulsky AG (1986) Human genetics, 2nd edn. Springer, Berlin Heidelberg New York

    Google Scholar 

  36. Bird A (1987) CpG islands as gene markers in the vertebrate nucleus. Trends Genet 3:342–347

    Article  CAS  Google Scholar 

  37. Suzuki T, Yokota J, Mugishima H, Okabe I, Sugimura T, Terada M (1989) Frequent loss of heterozygosity on chromosome 14q in neuroblastoma. Cancer Res 49:1095–1098

    PubMed  CAS  Google Scholar 

  38. Schwab M (1985) Amplification of N-myc in human neuroblastomas. Trends Genet 1:271–275

    Article  CAS  Google Scholar 

  39. Schwab M (1986) Amplification of proto-oncogenes and tumor progression. In Kahn P, Graf T (eds) Oncogenes and growth control. Springer, Berlin Heidelberg New York, pp 332–339

    Chapter  Google Scholar 

  40. Bishop JM (1987) The molecular genetics of cancer. Science 235:305–311

    Article  PubMed  CAS  Google Scholar 

  41. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, Press MF (1989) Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244:707–712

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Schwab, M. (1992). Human Neuroblastoma: Paradigm for a Tumor with Oncogene Amplification and Loss of a Putative Tumor Suppressor Gene. In: Neth, R., Frolova, E., Gallo, R.C., Greaves, M.F., Afanasiev, B.V., Elstner, E. (eds) Modern Trends in Human Leukemia IX. Haematology and Blood Transfusion / Hämatologie und Bluttransfusion, vol 35. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76829-3_36

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-76829-3_36

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-54360-2

  • Online ISBN: 978-3-642-76829-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics